AMOTL2 mono-ubiquitination by WWP1 promotes contact inhibition by facilitating LATS activation

Life Sci Alliance. 2021 Aug 17;4(10):e202000953. doi: 10.26508/lsa.202000953. Print 2021 Oct.

Abstract

Contact inhibition is a key cellular phenomenon that prevents cells from hyper-proliferating upon reaching confluence. Although not fully characterized, a critical driver of this process is the Hippo signaling pathway, whose downstream effector yes-associated protein plays pivotal roles in cell growth and differentiation. Here, we provide evidence that the E3 ligase WWP1 (WW-domain containing protein 1) mono-ubiquitinates AMOTL2 (angiomotin-like 2) at K347 and K408. Mono-ubiquitinated AMOTL2, in turn, interacts with the kinase LATS2, which facilitates recruitment of the upstream Hippo pathway component SAV1 and ultimately promotes yes-associated protein phosphorylation and subsequent cytoplasmic sequestration and/or degradation. Furthermore, contact inhibition induced by high cell density promoted the localization and stabilization of WWP1 at cell junctions, where it interacted with Crumbs polarity proteins. Notably, the Crumbs complex was functionally important for AMOTL2 mono-ubiquitination and LATS activation under high cell density conditions. These findings delineate a functionally important molecular mechanism in which AMOTL2 mono-ubiquitination by WWP1 at cell junctions and LATS activation are tightly coupled to upstream cell density cues.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiomotins / genetics
  • Angiomotins / metabolism*
  • Contact Inhibition* / genetics
  • Enzyme Activation
  • Humans
  • Phosphorylation
  • Protein Binding
  • Protein Serine-Threonine Kinases / genetics
  • Protein Serine-Threonine Kinases / metabolism*
  • Protein Transport
  • Tumor Suppressor Proteins / genetics
  • Tumor Suppressor Proteins / metabolism
  • Ubiquitin-Protein Ligases / genetics
  • Ubiquitin-Protein Ligases / metabolism*
  • Ubiquitination

Substances

  • AMOTL2 protein, human
  • Angiomotins
  • Tumor Suppressor Proteins
  • WWP1 protein, human
  • Ubiquitin-Protein Ligases
  • LATS1 protein, human
  • LATS2 protein, human
  • Protein Serine-Threonine Kinases